Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma
Clinical trial NCT00258206 · COMPLETED
Trial details
- NCT number
- NCT00258206
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-09-07
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.